InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,584.54
(
-0.88%
)
US TECH 100
19,682.80
(
0.03%
)
Dow Jones
39,753.75
(
0.08%
)
Brent Oil
85.64
(
0.62%
)
Bitcoin
57,019.17
(
-0.58%
)
Post# of 6386
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

USOB

Send PM Follow Ignore
Followers 0
Posts 511
Boards Moderated 0
Alias Born 01/16/2017

USOB

Re: Flaviker post# 5684

Tuesday, 04/18/2017 1:37:19 PM

Tuesday, April 18, 2017 1:37:19 PM

Post# of 6386
@Flaviker
There are obvious parties that are interested. Based on numerous 1st gen published clinical trials, the technology is accurate and reproducible with a MARD of ~ 12%. Total proof to justify further funding for the R&D needed to develop the Gen2 and Gen3 technology. MTIA was totally aware of this and was ready to provide the necessary funding to refine the product in order to bring it to the CDFA!
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up